BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 28
• 29
• 30

• BioForest

  BioMS Medical Provides Corporate Update; Company will Not Pursue Further Late Stage Clinical Trials with Dirucotide in MS

  December 18, 2009

   · 

  3 min read
• Deals

  Stockholders of CombinatoRx, Incorporated and Neuromed Pharmaceuticals Vote for Merger

  December 18, 2009

   · 

  1 min read
• Business

  Novation Awards Single Source Agreement to OrthoScan Inc.. for Mini C-Arms

  December 18, 2009

   · 

  1 min read
• Disparity in Use of Implantable Devices to Prevent Sudden Death in Heart Failure Patients

  December 18, 2009

   · 

  1 min read
• PAH Drug Outperforms Expectations

  December 18, 2009

   · 

  1 min read
• Business

  AEterna Zentaris, Sanofi-Aventis (France) End Prostate Drug Pact

  December 18, 2009

   · 

  2 min read
• Drug Development

  Cardiome Pharma Corp. Announces Investigational Candidate, Vernakalant, Meets Primary Endpoint in European Comparator Study

  December 18, 2009

   · 

  4 min read
• Policy

  Somaxon Pharmaceuticals, Inc. Scheduled to Meet with FDA to Discuss Complete Response Letter for Silenor(R) NDA

  December 18, 2009

   · 

  1 min read
• New Gene Linked To Congenital Heart Defects

  December 18, 2009

   · 

  1 min read
• Business

  Astellas Pharma Inc. (JOBS), Ambit Biosciences Join Hands on FLT3 Kinase Inhibitors; Ambit to Receive a $40 Million Upfront Cash Payment; Up to $350 Million in Pre-Commercialization Milestones

  December 18, 2009

   · 

  5 min read